Conversation with Jake Becraft of Strand Therapeutics on The Tim Ferriss Show podcast! The post Tim’s Founder Kitchen — From Brainstorm to the President’s Office in Two Months (Featuring Jake Becraft, Strand Therapeutics) (#868) appeared first on The Blog of Author Tim Ferriss.
“What I want the world to understand is that we are standing right now on the precipice of a revolution in genetic medicine.” — Jake Becraft
Jake Becraft is the CEO and Co-founder of Strand Therapeutics, a company building one of the most advanced programmable genetic medicine platforms in biotechnology. Under his leadership, Strand is redefining what RNA medicines can do by enabling cell-selective targeting and therapeutic payload delivery inside the body, unlocking a new class of precision genetic therapies. He has guided the company from its founding vision through platform development and into clinical translation, positioning Strand at the forefront of next generation RNA therapeutics.
Beyond his role at Strand, Dr. Becraft is an influential voice in the national biotechnology landscape. He engages and advises policymakers, defense leaders, and industry stakeholders on biosecurity, innovation strategy, and strengthening American competitiveness in advanced biotechnology. Trained as a synthetic biologist at MIT, he operates at the intersection of science, entrepreneurship, and policy, focused on building both the companies and the institutional frameworks required to secure the future of programmable medicine.
He received his Ph.D. in Biological Engineering and Synthetic Biology from MIT. He serves on the board of the Biotechnology Innovation Organization (BIO) and the Massachusetts Biotechnology Council (MassBio).
Please enjoy!
This episode is brought to you by:
- Helix Sleep premium mattresses: HelixSleep.com/Tim (20% off any purchase)
- Incogni, which automatically removes your personal data from the web, helping shield you from fraud, scams, and identity theft: Incogni.com/Tim (use code TIM at checkout and get 60% off an annual plan)
Additional podcast platforms
Listen to this episode on Apple Podcasts, Spotify, Overcast, Podcast Addict, Pocket Casts, Castbox, YouTube Music, Amazon Music, Audible, or on your favorite podcast platform.
Transcripts
- This episode (coming soon)
- All episodes
SELECTED LINKS FROM THE EPISODE
- Connect with Jacob Becraft:
Books & Recommended Reading
- Genentech: The Beginnings of Biotech by Sally Smith Hughes | Amazon
- The US Can’t Afford to Offshore Clinical Trials to China by Jacob Becraft | The Washington Post
- Strand Therapeutics Announces Initial First-in-Human Phase 1 Data for STX-001 at the 2025 ASCO Annual Meeting | BioSpace
- STX-001 ASCO Poster | Journal of Clinical Oncology
- The Nobel Prize: Checkpoint Inhibitors | American Journal of Managed Care
- Scientists Create In Vivo CAR-T Therapy That Kills Cancer Cells Without Chemotherapy | Innovative Genomics Institute
- mRNA Startup Strand Therapeutics Lands $52M to “Program” New Cancer Therapies | MedCity News
- The Abscopal Effect in the Era of Checkpoint Inhibitors | National Library of Medicine
- Step 1: Collect Underpants, Step 2: ?, Step 3: Profit | Know Your Meme
- Biologics: The Role of Delivery Systems in Improved Therapy | Biologics
- How the Late Genzyme CEO Henri Termeer Created the Orphan Drug Industry | BioCentury
- The Orphan Drug Act (ODA) | Wikipedia
- The Recent Large Reduction in Space Launch Cost | NASA Technical Reports Server
- FDA Rejects MDMA, Disappointing Drugmaker Lykos and the Psychedelics Industry | NPR
- Methylone: Distinct Pharmacological and Mechanistic Effects Compared with MDMA | Transcend Therapeutics
- Curing HIV — How Far Have We Come? | amfAR
- How Has US Spending on Healthcare Changed over Time? | Peterson-KFF Health System Tracker
- Strand Tx CEO Jake Becraft Weighs in on FDA’s IND Reform, China | Fierce Biotech
- Testimony of Dr. Jacob Becraft Before the House Select Committee on the CCP | US House of Representatives
- Why More Biotechs Are Starting Trials in Australia | Clinical Leader
- SpaceX Vehicles: From Falcon 1 to Starship | SpaceX
- Strand’s Flywheel: Platforms for Tumor and T-Cell Delivery | Kinnevik
- Domino’s Pizza Turnaround Case Study | Dennis Food Service
- Rides for Vaccinations | Uber Impact
- AlphaFold: Predicting Protein Structures with AI | Google DeepMind
- Elon Musk Went from Having 180 Million to Nearly Losing Everything | Leading Entrepreneurs
- All of Jeff Bezos’ Amazon Letters to Shareholders, 1997–2020 | Quartr
- AWS: Amazon’s “Side Hustle” That Reshaped the Cloud | About Amazon
- How Josh Kushner Built Thrive Capital and Became a Billionaire Startup Investor | Fortune
- COVID-19 Isn’t Political; Its Response Shouldn’t Be Politicized | Johns Hopkins Bloomberg School of Public Health
- From Insulin to Humulin: The Story of the First Genetically Engineered Drug | Genetics Unzipped
- Herceptin (Trastuzumab): The First HER2-Targeted Cancer Therapy | Genentech
- This Month in 1989: The Creation of Bristol-Myers Squibb | PMLiVE
- “Short the Launch”: Biotech from Bust to Boom | BayBridge Bio
- Arthur D. Levinson: From Genentech CEO to Apple Chairman | The Franklin Institute
- Apple, Its Control Over the iPhone, and The Internet | Matthew Ball
- How Smartphones Changed Music and the Music Industry | Hypebot
- This May Be the Most Important Medical Story of the Decade | The New York Times
Movies
- Sophie’s Choice | Prime Video
Companies
- Strand Therapeutics
- Amazon
- Andreessen Horowitz
- Anthropic
- Apple
- Amazon Web Services (AWS)
- BlackBerry
- Bristol Myers Squibb (BMS)
- DeepMind
- Domino’s Pizza
- Genentech
- Genzyme
- Holobiome
- Merck
- Meta
- Microsoft
- Moderna
- Netflix
- The New York Times
- OpenAI
- PayPal
- PickFu
- Playground Global
- Polymarket
- SpaceX
- Spotify
- Sweetgreen
- Tesla
- Thrive Capital
- Uber
- Uber Eats
- The Washington Post
- Zenno
- Zip2
Institutions & Organizations
- American Society of Clinical Oncology (ASCO)
- Advanced Research Projects Agency for Health (ARPA-H)
- Center for Biologics Evaluation and Research (CBER)
- Congress (US)
- Defense Advanced Research Projects Agency (DARPA)
- Department of Health (Abu Dhabi)
- European Medicines Agency (EMA)
- Food and Drug Administration (FDA)
- Institutional Review Board (IRB)
- Medicaid
- Medicare
- MIT
- MIT Media Lab
- MD Anderson Cancer Center
- Memorial Sloan Kettering Cancer Center
- Nobel Prize
- Saisei Foundation
- The White House
Concepts & Therapies
- 80/20 Rule (Pareto Principle)
- Abscopal Effect in Oncology
- American Society of Clinical Oncology (ASCO) Annual Meeting
- Australia’s Clinical Trial Notification (CTN) Scheme
- CAR-T Cell Therapy: Cost and Manufacturing Challenges
- The Central Dogma of Molecular Biology (DNA -> RNA -> Protein)
- Checkpoint Inhibitors and Cancer Immunotherapy
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Cost of Goods Sold (COGS)
- Cutaneous vs. Visceral Metastases in Melanoma
- FDA Investigational New Drug (IND) Application
- First Principles Thinking
- In Vivo CAR-T Cell Therapy
- Institutional Review Boards (IRBs) and Clinical Trial Oversight
- Kaplan-Meier Survival Curves
- Keytruda (Pembrolizumab) by Merck
- Opdivo (Nivolumab) by Bristol Myers Squibb
- mRNA-Based Therapeutics
- mRNA Vaccines for COVID-19
- Strand’s STX-001: Phase 1 Trial in Solid Tumors
- Turing Test
People
- Jeff Bezos
- Jennifer Doudna
- Jamie Heywood
- Jony Ive
- Steve Jobs
- Steve Jurvetson
- Baby KJ
- Josh Kushner
- Art Levinson
- Martin Makary
- Elon Musk
- Sundar Pichai
- Vinay Prasad
- Phil Strandwitz
- Henri Termeer
- Alan Turing
Relevant Episodes
- Rick Doblin — The Psychedelic Domino That Tips All Others (#440) | The Tim Ferriss Show
- Dr. Suresh Muthukumaraswamy — LSD Microdosing, Classical Psychedelics vs. Ketamine, Science and Speed in New Zealand (#619) | The Tim Ferriss Show
- Steve Jurvetson — How to Pick the Future, Quantum Computing, SpaceX, Tesla, and More (#714) | The Tim Ferriss Show
- Walter Isaacson on CRISPR, Jennifer Doudna, Gene Editing, and the Future of the Human Race (#503) | The Tim Ferriss Show
TIMESTAMPS
- [00:00:00] Start.
- [00:06:07] What Strand does.
- [00:08:19] The Boston dinner.
- [00:11:05] The image of a body riddled with cancer.
- [00:15:05] What stuck for the muggles in the pitch deck.
- [00:17:14] A good drug vs. a good product.
- [00:19:40] Tricking cancer into snitching on itself.
- [00:27:38] The abscopal effect.
- [00:34:04] Potency, specificity, and delivery.
- [00:35:46] First principles thinking.
- [00:36:38] The precipice of a revolution.
- [00:41:14] The thousand people in the room.
- [00:48:38] Psychedelic medicine as a cautionary tale.
- [00:51:17] What actually catches a policymaker’s attention.
- [00:53:42] Breakthrough vs. incremental.
- [00:54:55] What’s in it for the policymakers?
- [00:58:08] The 80/20 wish list.
- [01:01:31] Australia’s CTN system.
- [01:03:51] Sheep, psychedelics, and red-tape arbitrage.
- [01:05:22] China’s clinical-trial flywheel vs. slow-motion American loss.
- [01:06:53] The bicoastal biotech ethos.
- [01:08:10] Can the FDA actually pull this off?
- [01:12:12] The Sophie’s Choice of pharma development.
- [01:14:16] Lost arts of founder mode.
- [01:15:23] Rockets for tumors, T-cells, and beyond.
- [01:19:16] Viral in policy circles.
- [01:23:09] The Washington Post headline and the PickFu split test.
- [01:27:56] Solution-first storytelling.
- [01:33:54] RNA medicine and platform therapeutics.
- [01:39:17] Moderna’s 62 days.
- [01:40:33] Uber Eats and the de-risked launch.
- [01:44:17] CEO blockers.
- [01:45:52] Where’s biotech’s SpaceX moment?
- [01:46:53] Elon Musk betting black on the wheel.
- [01:51:55] AWS and the post-conviction / pre-consensus window.
- [01:58:47] COVID politicization.
- [01:59:46] Insulin, growth hormone, and the original platform story.
- [02:01:35] Biotech as pharma’s little brother.
- [02:03:29] More recent role models, Apple edition.
- [02:04:50] Art Levinson, Steve Jobs, and the biotech-tech crossover.
- [02:06:25] The iPhone as a delivery platform.
- [02:08:25] Spotify’s problem and the future of bespoke medicine.
- [02:10:07] Baby KJ and the limits of liver-only solutions.
- [02:11:19] Parting thoughts.
JACOB BECRAFT QUOTES FROM THE INTERVIEW
“Our goal at Strand, and our challenge, is building drugs today that impact patients’ lives. We’re not a research institute. Our goal is not to do really cool research on mice and join the ranks of people who have cured mice of cancer. There’s millions of them. There could be a Nobel Prize every five minutes for someone who’s cured a mouse of cancer. Our goal is to cure human beings of human-being cancer. Our goal is to cure human beings of human-being diseases, and do so in a safe, effective, scalable way that impacts a person’s life as little as possible. And that is what we’re building.”
— Jacob Becraft
“What I want the world to understand is that we are standing right now on the precipice of a revolution in genetic medicine.”
— Jacob Becraft
“Everyone wants to cure cancer. I don’t need a story behind curing cancer. I just need a story about how we’re going to get there and how curing cancer is actually going to be one step on the road to solving disease writ large.”
— Jacob Becraft
“No one will learn until they care.”
— Jacob Becraft
“The biotechnology industry will be dragged kicking and screaming into the future, or it will be built up in a new way from new players.”
— Jacob Becraft
“If some bullshit hype filters into this, it’s worth it in order to take the correct swings at the truly big ideas, because one out of 10 transformations is better than seven out of 10 logical steps forward.”
— Jacob Becraft
“Capital has no allegiance.”
— Jacob Becraft
“In low odds games, games where there’s a very low odds of success statistically, if you don’t go 100 percent all in, the odds will be zero.”
— Jacob Becraft
“When I look at some of those great investors who have made these high conviction bets, it seems like they’re able to identify this moment in time for companies that is post-conviction, pre-consensus. The ones who know we’re post-conviction. We’re no longer saying, ‘Can we do this?’ We’re like, ‘Oh, my God, this is going to work.’ But it’s pre-consensus because not everyone has caught on yet or not everyone is convinced.”
— Jacob Becraft
Want to hear another episode with a physician-founder building a new class of medicine? Listen to my conversation with Dr. Kevin Tracey, president and CEO of the Feinstein Institutes for Medical Research, in which we discussed the birth of bioelectronic medicine, stimulating the vagus nerve to tame inflammation, the inflammatory reflex, treating rheumatoid arthritis and Crohn’s disease, SetPoint Medical’s FDA approval journey, alleviating depression and autoimmune disorders, building devices that replace drugs, and much more.
This episode is brought to you by Incogni: erase your personal data from the web and prevent scams, fraud, and identity theft! Incogni automatically removes your information across 420+ data brokers (1,000+ additional sites covered in their Unlimited plan), and they keep it scrubbed automatically. Deloitte has independently verified the headline numbers (245M+ removal requests), and the company adheres to AICPA SOC security standards, with an A+ rating from the BBB. And with their Unlimited plan, if you find your info on a site they don’t automatically monitor, just send them the link, and their privacy team will handle it. Protect yourself now with Incogni. Go to Incogni.com/Tim to get 60% off their annual plan.
This episode is brought to you by Helix Sleep! Helix was selected as the best overall mattress of 2025 by Forbes and Wired magazines and best in category by Good Housekeeping, GQ, and many others. With Helix, there’s a specific mattress to meet each and every body’s unique comfort needs. Just take their quiz—only two minutes to complete—that matches your body type and sleep preferences to the perfect mattress for you. They have a 10-year warranty, and you get to try it out for a hundred nights, risk-free. They’ll even pick it up from you if you don’t love it. And now, Helix is offering listeners 20% off all mattress orders for a limited time at HelixSleep.com/Tim.
The post Tim’s Founder Kitchen — From Brainstorm to the President’s Office in Two Months (Featuring Jake Becraft, Strand Therapeutics) (#868) appeared first on The Blog of Author Tim Ferriss.









